BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeifman RJ, Wagner AC, Watts R, Kettner H, Mertens LJ, Carhart-Harris RL. Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation. Front Psychiatry 2020;11:782. [PMID: 32903724 DOI: 10.3389/fpsyt.2020.00782] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Breeksema JJ, Niemeijer A, Kuin B, Veraart J, Kamphuis J, Schimmel N, van den Brink W, Vermetten E, Schoevers R. Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study. Front Psychiatry 2022;13. [DOI: 10.3389/fpsyt.2022.948115] [Reference Citation Analysis]
2 Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L. The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world. Psychopharmacology (Berl) 2022. [PMID: 35939083 DOI: 10.1007/s00213-022-06187-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yaden DB, Earp D, Graziosi M, Friedman-Wheeler D, Luoma JB, Johnson MW. Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default. Front Psychol 2022;13:873279. [PMID: 35677124 DOI: 10.3389/fpsyg.2022.873279] [Reference Citation Analysis]
4 Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-harris R. Increased global integration in the brain after psilocybin therapy for depression. Nat Med. [DOI: 10.1038/s41591-022-01744-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 34] [Article Influence: 22.0] [Reference Citation Analysis]
5 Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-beiner A, Baker-jones M, Nutt D, Erritzoe D, Watts R, Carhart-harris R. Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. Front Pharmacol 2022;12:788155. [DOI: 10.3389/fphar.2021.788155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Hearn BG, Brubaker MD, Richardson G. Counselors’ attitudes toward psychedelics and their use in therapy. Jour of Counseling & Develop. [DOI: 10.1002/jcad.12429] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Rossi GN, Dias ICDS, Baker G, Bouso Saiz JC, Dursun SM, Hallak JEC, Dos Santos RG. Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability. Expert Opin Drug Saf 2022. [PMID: 35301934 DOI: 10.1080/14740338.2022.2054988] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Raison CL, Jain R, Penn AD, Cole SP, Jain S. Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States. Front Psychiatry 2022;13:831092. [DOI: 10.3389/fpsyt.2022.831092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Agin-liebes G, Zeifman R, Luoma JB, Garland EL, Campbell WK, Weiss B. Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca. J Psychopharmacol 2022;36:295-308. [DOI: 10.1177/02698811221080165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Wolff M, Mertens LJ, Walter M, Enge S, Evens R. The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility. J Psychopharmacol 2022;36:387-408. [DOI: 10.1177/02698811211073758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V. Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective. Front Psychiatry 2021;12:800072. [PMID: 34975593 DOI: 10.3389/fpsyt.2021.800072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
12 Khan AJ, Bradley E, O’donovan A, Woolley J. Psilocybin for Trauma-Related Disorders. Disruptive Psychopharmacology 2022. [DOI: 10.1007/7854_2022_366] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Kuburi S, Di Passa A, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V. Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review. Chronic Stress 2022;6:247054702211153. [DOI: 10.1177/24705470221115342] [Reference Citation Analysis]
14 Vilca-Melendez S, Uthaug MV, Griffin JL. 1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids? Front Psychiatry 2021;12:742856. [PMID: 34966300 DOI: 10.3389/fpsyt.2021.742856] [Reference Citation Analysis]
15 Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC, Alderton KL, Williams TM, Blemings A, Lafrance A, Nicholls DE, Erritzoe D, Nutt DJ, Carhart-Harris RL. Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study". Front Psychiatry 2021;12:735523. [PMID: 34744825 DOI: 10.3389/fpsyt.2021.735523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Hearn B. Psychedelics, Mystical Experiences, and Meaning Making: A Renegotiation Process With the Challenges of Existence. The Journal of Humanistic Counseling 2021;60:180-96. [DOI: 10.1002/johc.12164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Artru E, Rabeyron T. Psychédéliques, psychothérapie et symbolisation : une revue de littérature dans le champ de la dépression. L'Évolution Psychiatrique 2021;86:591-616. [DOI: 10.1016/j.evopsy.2021.03.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Hübner S, Haijen E, Kaelen M, Carhart-Harris RL, Kettner H. Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use. J Med Internet Res 2021;23:e25973. [PMID: 34319246 DOI: 10.2196/25973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Rabeyron T. Beyond the death drive: Entropy and free energy. Int J Psychoanal 2021;102:878-905. [PMID: 34284698 DOI: 10.1080/00207578.2021.1932514] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
20 Kočárová R, Horáček J, Carhart-Harris R. Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential? Front Psychiatry 2021;12:661233. [PMID: 34349678 DOI: 10.3389/fpsyt.2021.661233] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
21 Mans K, Kettner H, Erritzoe D, Haijen ECHM, Kaelen M, Carhart-Harris RL. Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample. Front Psychiatry 2021;12:647909. [PMID: 34267683 DOI: 10.3389/fpsyt.2021.647909] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L. The Therapeutic Potential of Psilocybin. Molecules 2021;26:2948. [PMID: 34063505 DOI: 10.3390/molecules26102948] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 15.0] [Reference Citation Analysis]
23 Kettner H, Rosas FE, Timmermann C, Kärtner L, Carhart-Harris RL, Roseman L. Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness. Front Pharmacol 2021;12:623985. [PMID: 33995022 DOI: 10.3389/fphar.2021.623985] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 38.0] [Reference Citation Analysis]
24 Agin-Liebes G, Haas TF, Lancelotta R, Uthaug MV, Ramaekers JG, Davis AK. Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes. ACS Pharmacol Transl Sci 2021;4:543-52. [PMID: 33860184 DOI: 10.1021/acsptsci.1c00018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
25 Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, Mennenga SE. Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer. ACS Pharmacol Transl Sci 2021;4:553-62. [PMID: 33860185 DOI: 10.1021/acsptsci.1c00020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
26 Payne JE, Chambers R, Liknaitzky P. Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice. ACS Pharmacol Transl Sci 2021;4:416-23. [PMID: 33860171 DOI: 10.1021/acsptsci.1c00034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
27 Zeifman RJ, Singhal N, Breslow L, Weissman CR. On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review. ACS Pharmacol Transl Sci 2021;4:436-51. [PMID: 33860173 DOI: 10.1021/acsptsci.1c00024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
28 Mcculloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM. Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.. [DOI: 10.1101/2021.01.28.428377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Hübner S, Haijen E, Kaelen M, Carhart-harris RL, Kettner H. Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use (Preprint).. [DOI: 10.2196/preprints.25973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Kangaslampi S. Uncovering psychological mechanisms mediating the effects of drugs: some issues and comments using the example of psychedelic drugs. Psychopharmacology (Berl) 2020;237:3799-802. [PMID: 33151375 DOI: 10.1007/s00213-020-05703-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
31 Zeifman RJ, Singhal N, Dos Santos RG, Sanches RF, de Lima Osório F, Hallak JEC, Weissman CR. Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial. Psychopharmacology (Berl) 2021;238:453-9. [PMID: 33118052 DOI: 10.1007/s00213-020-05692-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]